Prospective, randomized, double-blind phase 2B trial of the TLPO and TLPLDC vaccines to prevent recurrence of resected stage III/IV melanoma: a prespecified 36-month analysis
Elizabeth Lee Carpenter, Spencer Van Decar, Alexandra M. Adams, Anne E. O'Shea, Patrick McCarthy, Robert Connor Chick, Guy Travis Clifton, Timothy Vreeland, Franklin A. Valdera, Ankur Tiwari, Diane Hale, Phillip Kemp Bohan, Annelies Hickerson, Todd Smolinsky, Katryna Thomas, Jessica Cindass, John Hyngstrom, Adam C. Berger, James Jakub, Jeffrey J. SussmanMontaser F. Shaheen, Xianzhong Yu, Thomas E. Wagner, Mark Faries, George E. Peoples
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Prospective, randomized, double-blind phase 2B trial of the TLPO and TLPLDC vaccines to prevent recurrence of resected stage III/IV melanoma: a prespecified 36-month analysis'. Together they form a unique fingerprint.